Misplaced Pages

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 13:06, 9 August 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'StdInChIKey').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ibrolipim

Names
IUPAC name diethyl {4-benzyl}phosphonate
Identifiers
3D model (JSmol)	Interactive image
ChemSpider	116297
ECHA InfoCard	100.162.319
KEGG	D03747
PubChem CID	131601
CompTox Dashboard (EPA)	DTXSID20157989
InChI InChI=StdInChI=1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23)Key: KPRTURMJVWXURQ-UHFFFAOYSA-N InChI=1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23) InChI=1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23)Key: KPRTURMJVWXURQ-UHFFFAOYSA-N
SMILES Brc2cc(C#N)c(NC(=O)c1ccc(cc1)CP(=O)(OCC)OCC)cc2
Properties
Chemical formula	C19H20BrN2O4P
Molar mass	451.25
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references

Ibrolipim (NO-1886) is a cholesterol lowering drug from the statin family, which acts as a lipoprotein lipase activator. The discovery of the “statin” mevalonic acid synthesis inhibitors focused new attention on control of blood lipid levels as a measure to stave off heart disease. A number of compounds have been found that treat elevated lipid levels by other diverse mechanisms. The phosphonic acid derivative ibrolipim is believed to lower those levels by accelerating fatty acid oxidation.

References

1. Yin W, Tsutsumi K (2003). "Lipoprotein lipase activator NO-1886". Cardiovascular Drug Reviews. 21 (2): 133–42. PMID 12847564.

• Statins
• Organobromides
• Nitriles
• Benzanilides
• Phosphonate esters